Literature search for the LSD1 related publications and micro-array mRNA data from the Cancer Genome Anatomy Project database (http://cgap.nci.nih.gov/Microarray/GeneList) in several cancer cell lines collected by the National Cancer Institute revealed two myeloid differentiation markers, CD11b and CD86, are potential targeted genes of LSD1 in AML [1, 2, 27, 35, 45, 46]. This evidence concerns the gene ITGAM and cancer.